Review



1 ap  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc 1 ap
    1 Ap, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 63 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sav1/SAV1+Rabbit+mAb/pm41926287-1020-159-176
    Average 94 stars, based on 63 article reviews
    1 ap - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: cis-Clerodane-type diterpenoids from Tinospora crispa and their anticancer potential.
    Article Snippet: .. Membranes were blocked with 2% skim milk in TBST at 4 °C and then incubated overnight at 4 °C with the following primary antibodies: MST1 (1:1000, #14,946, Cell Signaling Technology), SAV1 (1:1000, #13301S, Cell Signaling Technology), MOB1 (1:1000, #13730S, Cell Signaling Technology), LATS1 (1:1000, #3477S, Cell Signaling Technology), phosphoYAP (p-YAP; 1:1000, #4911S, Cell Signaling Technology), YAP (1:1000, #14,074, Cell Signaling Technology), TAZ (1:1000, #83669S, Cell Signaling Technology), pan-TEAD (1:1000, #13295S, Cell Signaling Technology), phosphoAKT (p-AKT; 1:1000, #9275S, Cell Signaling Technology), AKT (1:1000, #9272S, Cell Signaling Technology), phospho-ERK1/2 (p-ERK1/2; 1:1000, #PAB16949, Abnova), total ERK1/2 (1:1000, #9102S, Cell Signaling Technology), STAT3 (1:1000, #9139S, Cell Signaling Technology), Cyclin D1 (1:1000, sc-8396, Santa Cruz Biotechnology), Waf1/Cip1/CDKN1A p21 (1:1000, sc-53870, Santa Cruz Biotechnology), Bax (1:1000, sc-23959, Santa Cruz Biotechnology), Bcl-2 (1:1000, sc-23960, Santa Cruz Biotechnology), Caspase-3 (1:1000, sc-56053, Santa Cruz Biotechnology), and E-cadherin (1:1000, #3195, Cell Signaling Technology). .. After washing, membranes were incubated with HRP-conjugated secondary antibodies: anti-mouse IgG (1:2000, #7076P2, Cell Signaling Technology) or antirabbit IgG (1:2000, #7074S, Cell Signaling Technology).

    Article Title: cis -Clerodane-type diterpenoids from Tinospora crispa and their anticancer potential
    Article Snippet: .. Membranes were blocked with 2% skim milk in TBST at 4 °C and then incubated overnight at 4 °C with the following primary antibodies: MST1 (1:1000, #14,946, Cell Signaling Technology), SAV1 (1:1000, #13301S, Cell Signaling Technology), MOB1 (1:1000, #13730S, Cell Signaling Technology), LATS1 (1:1000, #3477S, Cell Signaling Technology), phospho-YAP (p-YAP; 1:1000, #4911S, Cell Signaling Technology), YAP (1:1000, #14,074, Cell Signaling Technology), TAZ (1:1000, #83669S, Cell Signaling Technology), pan-TEAD (1:1000, #13295S, Cell Signaling Technology), phospho-AKT (p-AKT; 1:1000, #9275S, Cell Signaling Technology), AKT (1:1000, #9272S, Cell Signaling Technology), phospho-ERK1/2 (p-ERK1/2; 1:1000, # PAB16949 , Abnova), total ERK1/2 (1:1000, #9102S, Cell Signaling Technology), STAT3 (1:1000, #9139S, Cell Signaling Technology), Cyclin D1 (1:1000, sc-8396, Santa Cruz Biotechnology), Waf1/Cip1/CDKN1A p21 (1:1000, sc-53870, Santa Cruz Biotechnology), Bax (1:1000, sc-23959, Santa Cruz Biotechnology), Bcl-2 (1:1000, sc-23960, Santa Cruz Biotechnology), Caspase-3 (1:1000, sc-56053, Santa Cruz Biotechnology), and E-cadherin (1:1000, #3195, Cell Signaling Technology). .. After washing, membranes were incubated with HRP-conjugated secondary antibodies: anti-mouse IgG (1:2000, #7076P2, Cell Signaling Technology) or anti-rabbit IgG (1:2000, #7074S, Cell Signaling Technology).

    other:

    Article Title: The serotonin receptor 2b (5-HT 2B ) modulates heart remodeling following myocardial infarction via regulation of Hippo pathway
    Article Snippet: Sav1 , Cell Signalling Technologies , Cat #13301; RRID:AB_2798176.

    Article Title: Hernandonine-mediated autophagic cell death in hepatocellular carcinoma: Interplay of p53 and YAP signaling pathways.
    Article Snippet: Hepatocellular carcinoma (HCC), the primary form of liver cancer, is the third leading cause of cancer-related death globally.. Hernandonine is a natural alkaloid derived from Hernandia nymphaeifolia that has been shown to exert various biological functions.. In a previous study, hernandonine was shown to suppress the proliferation of several solid tumor cell lines without affecting normal human cell lines.

    Western Blot:

    Article Title: MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentials
    Article Snippet: Subsequently, the membrane was washed four times with 1 × TBST buffer (Catalog Number: 9997S, Cell Signaling Technology, USA) for 8 min each. .. For western blot analysis, specific antibodies were used to detect target proteins, including MST1 (Catalog Number: 3682S, Cell Signaling Technology, USA), LATS1 (Catalog Number: 3477S, Cell Signaling Technology, USA), YAP (Catalog Number: 14074S, Cell Signaling Technology, USA), SAV1 (Catalog Number: 13301S, Cell Signaling Technology, USA), and MOB1 (Catalog Number: 13730S, Cell Signaling Technology, USA). ..

    Article Title: MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentials.
    Article Snippet: Subsequently, the membrane was washed four times with 1 × TBST buffer (Catalog Number: 9997S, Cell Signaling Technology, USA) for 8 min each. .. For western blot analysis, specific antibodies were used to detect target proteins, including MST1 (Catalog Number: 3682S, Cell Signaling Technology, USA), LATS1 (Catalog Number: 3477S, Cell Signaling Technology, USA), YAP (Catalog Number: 14074S, Cell Signaling Technology, USA), SAV1 (Catalog Number: 13301S, Cell Signaling Technology, USA), and MOB1 (Catalog Number: 13730S, Cell Signaling Technology, USA). ..

    Article Title: Hippo pathway deficiency reverses systolic heart failure post-infarction
    Article Snippet: Samples were homogenized with a Dounce tissue homogenizer, passed through a 22-gauge needle, and sonicated for ten cycles (30 s on, 30 s off) in a Diagenode Bioruptor Pico Plus NGS. .. For western blot analysis, we used antibodies against total YAP (Novus NB110-58358), pYAP (Cell Signaling 4911S), pLats1 (Cell Signaling 9157), Sav1 (Novus NBP2-13282), Park2 (Cell Signaling 2132S), and α-tubulin (Sigma T5168). ..



    Similar Products

    94
    Cell Signaling Technology Inc 1 ap
    1 Ap, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sav1/SAV1+Rabbit+mAb/pm41926287-1020-159-176
    Average 94 stars, based on 1 article reviews
    1 ap - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc phospho yap ser397 lats1 phospho mob1 lats1 phospho mob1 thr35 mob1 mst1 mst2 sav1 phospho yap
    Phospho Yap Ser397 Lats1 Phospho Mob1 Lats1 Phospho Mob1 Thr35 Mob1 Mst1 Mst2 Sav1 Phospho Yap, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sav1/YAP%2FTAZ+Rabbit+mAb/pmc13025875-6-0-13
    Average 96 stars, based on 1 article reviews
    phospho yap ser397 lats1 phospho mob1 lats1 phospho mob1 thr35 mob1 mst1 mst2 sav1 phospho yap - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc sav1
    Regulation of the Hippo pathway by 5-HT 2B in cardiomyocytes (A) Western blot confirmation that Ad-FLAG-5-HT 2B infection in NRCMs resulted in the expression of FLAG- 5-HT 2B that was absent in Ad-LacZ-infected controls (representative image of n = 3 independent experiments). (B) YAP transcriptional activity was enhanced in NRCMs following 5-HT 2B overexpression ( n = 5 independent experiments with five technical replications in each experiment). (C) Representative images of GFP-YAP nuclear translocation in NRCMs overexpressing 5-HT 2B or control LacZ (scale bars, 100 μm). (D) Quantification of NRCMs with nuclear GFP-YAP showed that cells overexpressing 5-HT 2B exhibited a higher proportion of nuclear YAP ( n = 5 independent experiments with three technical replicates in each prep). (E and F) (E) Western blots and (F) quantification of band density showing a reduction in YAP phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (G and H) (G) Western blots and (H) quantification of band density showing a significant reduction in LATS1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (I and J) (I) Western blots and (J) quantification of band density showing no significant change in MST1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K–M) (K) Western blots and (L) quantification of band density showing a reduction in expression of the LATS1 adaptor protein MOB1 in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K) Western blots and (M) quantification of band density showing no change in expression of the MST adaptor protein <t>Sav1</t> in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (N and O) (N) Western blots and (O) quantification of MYPT1 phosphorylation in NRCMs overexpressing 5-HT 2B indicated a possible role for ROCK1 linking 5-HT 2B with the Hippo pathway ( n = 3 independent experiments). (P) Immunoprecipitation analysis in cardiomyocytes overexpressing Flag-5-HT 2B using anti-Flag antibody followed by western blot detection using anti-LATS1 indicated possible interaction between 5-HT 2B and LATS1. All data are presented as mean ± SEM. Statistical tests used: (B, D, F, H, J, L, M, and O) Student’s t test.
    Sav1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sav1/SAV1+Rabbit+mAb/pmc12915196-7-0-2
    Average 94 stars, based on 1 article reviews
    sav1 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc plats1 ser909 cell signalling technologies
    Regulation of the Hippo pathway by 5-HT 2B in cardiomyocytes (A) Western blot confirmation that Ad-FLAG-5-HT 2B infection in NRCMs resulted in the expression of FLAG- 5-HT 2B that was absent in Ad-LacZ-infected controls (representative image of n = 3 independent experiments). (B) YAP transcriptional activity was enhanced in NRCMs following 5-HT 2B overexpression ( n = 5 independent experiments with five technical replications in each experiment). (C) Representative images of GFP-YAP nuclear translocation in NRCMs overexpressing 5-HT 2B or control LacZ (scale bars, 100 μm). (D) Quantification of NRCMs with nuclear GFP-YAP showed that cells overexpressing 5-HT 2B exhibited a higher proportion of nuclear YAP ( n = 5 independent experiments with three technical replicates in each prep). (E and F) (E) Western blots and (F) quantification of band density showing a reduction in YAP phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (G and H) (G) Western blots and (H) quantification of band density showing a significant reduction in LATS1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (I and J) (I) Western blots and (J) quantification of band density showing no significant change in MST1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K–M) (K) Western blots and (L) quantification of band density showing a reduction in expression of the LATS1 adaptor protein MOB1 in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K) Western blots and (M) quantification of band density showing no change in expression of the MST adaptor protein <t>Sav1</t> in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (N and O) (N) Western blots and (O) quantification of MYPT1 phosphorylation in NRCMs overexpressing 5-HT 2B indicated a possible role for ROCK1 linking 5-HT 2B with the Hippo pathway ( n = 3 independent experiments). (P) Immunoprecipitation analysis in cardiomyocytes overexpressing Flag-5-HT 2B using anti-Flag antibody followed by western blot detection using anti-LATS1 indicated possible interaction between 5-HT 2B and LATS1. All data are presented as mean ± SEM. Statistical tests used: (B, D, F, H, J, L, M, and O) Student’s t test.
    Plats1 Ser909 Cell Signalling Technologies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sav1/SAV1+Rabbit+mAb/10__1016_slash_j__isci__2026__114825-257-52-54
    Average 94 stars, based on 1 article reviews
    plats1 ser909 cell signalling technologies - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc sav1 cell signalling technologies
    Regulation of the Hippo pathway by 5-HT 2B in cardiomyocytes (A) Western blot confirmation that Ad-FLAG-5-HT 2B infection in NRCMs resulted in the expression of FLAG- 5-HT 2B that was absent in Ad-LacZ-infected controls (representative image of n = 3 independent experiments). (B) YAP transcriptional activity was enhanced in NRCMs following 5-HT 2B overexpression ( n = 5 independent experiments with five technical replications in each experiment). (C) Representative images of GFP-YAP nuclear translocation in NRCMs overexpressing 5-HT 2B or control LacZ (scale bars, 100 μm). (D) Quantification of NRCMs with nuclear GFP-YAP showed that cells overexpressing 5-HT 2B exhibited a higher proportion of nuclear YAP ( n = 5 independent experiments with three technical replicates in each prep). (E and F) (E) Western blots and (F) quantification of band density showing a reduction in YAP phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (G and H) (G) Western blots and (H) quantification of band density showing a significant reduction in LATS1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (I and J) (I) Western blots and (J) quantification of band density showing no significant change in MST1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K–M) (K) Western blots and (L) quantification of band density showing a reduction in expression of the LATS1 adaptor protein MOB1 in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K) Western blots and (M) quantification of band density showing no change in expression of the MST adaptor protein <t>Sav1</t> in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (N and O) (N) Western blots and (O) quantification of MYPT1 phosphorylation in NRCMs overexpressing 5-HT 2B indicated a possible role for ROCK1 linking 5-HT 2B with the Hippo pathway ( n = 3 independent experiments). (P) Immunoprecipitation analysis in cardiomyocytes overexpressing Flag-5-HT 2B using anti-Flag antibody followed by western blot detection using anti-LATS1 indicated possible interaction between 5-HT 2B and LATS1. All data are presented as mean ± SEM. Statistical tests used: (B, D, F, H, J, L, M, and O) Student’s t test.
    Sav1 Cell Signalling Technologies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sav1/MST2+Antibody/10__1016_slash_j__isci__2026__114825-257-46-47
    Average 95 stars, based on 1 article reviews
    sav1 cell signalling technologies - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology anti sav1
    Regulation of the Hippo pathway by 5-HT 2B in cardiomyocytes (A) Western blot confirmation that Ad-FLAG-5-HT 2B infection in NRCMs resulted in the expression of FLAG- 5-HT 2B that was absent in Ad-LacZ-infected controls (representative image of n = 3 independent experiments). (B) YAP transcriptional activity was enhanced in NRCMs following 5-HT 2B overexpression ( n = 5 independent experiments with five technical replications in each experiment). (C) Representative images of GFP-YAP nuclear translocation in NRCMs overexpressing 5-HT 2B or control LacZ (scale bars, 100 μm). (D) Quantification of NRCMs with nuclear GFP-YAP showed that cells overexpressing 5-HT 2B exhibited a higher proportion of nuclear YAP ( n = 5 independent experiments with three technical replicates in each prep). (E and F) (E) Western blots and (F) quantification of band density showing a reduction in YAP phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (G and H) (G) Western blots and (H) quantification of band density showing a significant reduction in LATS1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (I and J) (I) Western blots and (J) quantification of band density showing no significant change in MST1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K–M) (K) Western blots and (L) quantification of band density showing a reduction in expression of the LATS1 adaptor protein MOB1 in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K) Western blots and (M) quantification of band density showing no change in expression of the MST adaptor protein <t>Sav1</t> in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (N and O) (N) Western blots and (O) quantification of MYPT1 phosphorylation in NRCMs overexpressing 5-HT 2B indicated a possible role for ROCK1 linking 5-HT 2B with the Hippo pathway ( n = 3 independent experiments). (P) Immunoprecipitation analysis in cardiomyocytes overexpressing Flag-5-HT 2B using anti-Flag antibody followed by western blot detection using anti-LATS1 indicated possible interaction between 5-HT 2B and LATS1. All data are presented as mean ± SEM. Statistical tests used: (B, D, F, H, J, L, M, and O) Student’s t test.
    Anti Sav1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sav1/SAV1+Antibody/pmc12629034-72-6-10
    Average 91 stars, based on 1 article reviews
    anti sav1 - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology sav1
    EGFR interacts with <t>SAV1</t> and promotes YAP activation. A : Lysates from MIO-M1 Müller cells were co-immunoprecipitated with control immunoglobulin G (IgG) or anti-EGFR antibody, followed by immunoblotting with an anti-SAV1 antibody. n = 3 biological replicates. B : MIO-M1 Müller cells were transfected with flag-EGFR expression plasmid. The co-immunoprecipitation assay was performed using lysates from MIO-M1 Müller cells by an anti-flag antibody, followed by immunoblotting with an anti-SAV1 antibody. n = 3 biological replicates. C : Lysates from MIO-M1 Müller cells were co-immunoprecipitated with control IgG or anti-SAV1 antibody, followed by immunoblotting with an anti-EGFR antibody. n = 3 biological replicates. D : Representative SAV1 and EGFR double staining in the MIO-M1 Müller cells was examined by immunofluorescence (IF) staining. Scale bar = 20 µm. E : Western blot assay for EGFR, SAV1 and YAP expression in the MIO-M1 Müller cells through gain or loss of function of EGFR. n = 3 biological replicates. F : Expression of YAP in the nucleus of MIO-M1 Müller cells with gain or loss of function of EGFR was detected by Western blotting. n = 3 biological replicates. G : RT-PCR assay for mRNA levels of CTGF and CYR61 in MIO-M1 Müller cells through gain or loss of function of EGFR. n = 5 biological replicates. * p < 0.05; ** p < 0.01
    Sav1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sav1/SAV1+Antibody/pmc12629034-89-4-18
    Average 91 stars, based on 1 article reviews
    sav1 - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    Image Search Results


    Regulation of the Hippo pathway by 5-HT 2B in cardiomyocytes (A) Western blot confirmation that Ad-FLAG-5-HT 2B infection in NRCMs resulted in the expression of FLAG- 5-HT 2B that was absent in Ad-LacZ-infected controls (representative image of n = 3 independent experiments). (B) YAP transcriptional activity was enhanced in NRCMs following 5-HT 2B overexpression ( n = 5 independent experiments with five technical replications in each experiment). (C) Representative images of GFP-YAP nuclear translocation in NRCMs overexpressing 5-HT 2B or control LacZ (scale bars, 100 μm). (D) Quantification of NRCMs with nuclear GFP-YAP showed that cells overexpressing 5-HT 2B exhibited a higher proportion of nuclear YAP ( n = 5 independent experiments with three technical replicates in each prep). (E and F) (E) Western blots and (F) quantification of band density showing a reduction in YAP phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (G and H) (G) Western blots and (H) quantification of band density showing a significant reduction in LATS1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (I and J) (I) Western blots and (J) quantification of band density showing no significant change in MST1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K–M) (K) Western blots and (L) quantification of band density showing a reduction in expression of the LATS1 adaptor protein MOB1 in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K) Western blots and (M) quantification of band density showing no change in expression of the MST adaptor protein Sav1 in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (N and O) (N) Western blots and (O) quantification of MYPT1 phosphorylation in NRCMs overexpressing 5-HT 2B indicated a possible role for ROCK1 linking 5-HT 2B with the Hippo pathway ( n = 3 independent experiments). (P) Immunoprecipitation analysis in cardiomyocytes overexpressing Flag-5-HT 2B using anti-Flag antibody followed by western blot detection using anti-LATS1 indicated possible interaction between 5-HT 2B and LATS1. All data are presented as mean ± SEM. Statistical tests used: (B, D, F, H, J, L, M, and O) Student’s t test.

    Journal: iScience

    Article Title: The serotonin receptor 2b (5-HT 2B ) modulates heart remodeling following myocardial infarction via regulation of Hippo pathway

    doi: 10.1016/j.isci.2026.114825

    Figure Lengend Snippet: Regulation of the Hippo pathway by 5-HT 2B in cardiomyocytes (A) Western blot confirmation that Ad-FLAG-5-HT 2B infection in NRCMs resulted in the expression of FLAG- 5-HT 2B that was absent in Ad-LacZ-infected controls (representative image of n = 3 independent experiments). (B) YAP transcriptional activity was enhanced in NRCMs following 5-HT 2B overexpression ( n = 5 independent experiments with five technical replications in each experiment). (C) Representative images of GFP-YAP nuclear translocation in NRCMs overexpressing 5-HT 2B or control LacZ (scale bars, 100 μm). (D) Quantification of NRCMs with nuclear GFP-YAP showed that cells overexpressing 5-HT 2B exhibited a higher proportion of nuclear YAP ( n = 5 independent experiments with three technical replicates in each prep). (E and F) (E) Western blots and (F) quantification of band density showing a reduction in YAP phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (G and H) (G) Western blots and (H) quantification of band density showing a significant reduction in LATS1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (I and J) (I) Western blots and (J) quantification of band density showing no significant change in MST1 phosphorylation in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K–M) (K) Western blots and (L) quantification of band density showing a reduction in expression of the LATS1 adaptor protein MOB1 in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (K) Western blots and (M) quantification of band density showing no change in expression of the MST adaptor protein Sav1 in NRCMs overexpressing 5-HT 2B ( n = 3 independent experiments). (N and O) (N) Western blots and (O) quantification of MYPT1 phosphorylation in NRCMs overexpressing 5-HT 2B indicated a possible role for ROCK1 linking 5-HT 2B with the Hippo pathway ( n = 3 independent experiments). (P) Immunoprecipitation analysis in cardiomyocytes overexpressing Flag-5-HT 2B using anti-Flag antibody followed by western blot detection using anti-LATS1 indicated possible interaction between 5-HT 2B and LATS1. All data are presented as mean ± SEM. Statistical tests used: (B, D, F, H, J, L, M, and O) Student’s t test.

    Article Snippet: Sav1 , Cell Signalling Technologies , Cat #13301; RRID:AB_2798176.

    Techniques: Western Blot, Infection, Expressing, Activity Assay, Over Expression, Translocation Assay, Control, Phospho-proteomics, Immunoprecipitation

    EGFR interacts with SAV1 and promotes YAP activation. A : Lysates from MIO-M1 Müller cells were co-immunoprecipitated with control immunoglobulin G (IgG) or anti-EGFR antibody, followed by immunoblotting with an anti-SAV1 antibody. n = 3 biological replicates. B : MIO-M1 Müller cells were transfected with flag-EGFR expression plasmid. The co-immunoprecipitation assay was performed using lysates from MIO-M1 Müller cells by an anti-flag antibody, followed by immunoblotting with an anti-SAV1 antibody. n = 3 biological replicates. C : Lysates from MIO-M1 Müller cells were co-immunoprecipitated with control IgG or anti-SAV1 antibody, followed by immunoblotting with an anti-EGFR antibody. n = 3 biological replicates. D : Representative SAV1 and EGFR double staining in the MIO-M1 Müller cells was examined by immunofluorescence (IF) staining. Scale bar = 20 µm. E : Western blot assay for EGFR, SAV1 and YAP expression in the MIO-M1 Müller cells through gain or loss of function of EGFR. n = 3 biological replicates. F : Expression of YAP in the nucleus of MIO-M1 Müller cells with gain or loss of function of EGFR was detected by Western blotting. n = 3 biological replicates. G : RT-PCR assay for mRNA levels of CTGF and CYR61 in MIO-M1 Müller cells through gain or loss of function of EGFR. n = 5 biological replicates. * p < 0.05; ** p < 0.01

    Journal: Journal of Translational Medicine

    Article Title: The epidermal growth factor receptor regulates YAP signalling and promotes diabetic retinal fibrosis by modulating the degradation of SAV1

    doi: 10.1186/s12967-025-07357-7

    Figure Lengend Snippet: EGFR interacts with SAV1 and promotes YAP activation. A : Lysates from MIO-M1 Müller cells were co-immunoprecipitated with control immunoglobulin G (IgG) or anti-EGFR antibody, followed by immunoblotting with an anti-SAV1 antibody. n = 3 biological replicates. B : MIO-M1 Müller cells were transfected with flag-EGFR expression plasmid. The co-immunoprecipitation assay was performed using lysates from MIO-M1 Müller cells by an anti-flag antibody, followed by immunoblotting with an anti-SAV1 antibody. n = 3 biological replicates. C : Lysates from MIO-M1 Müller cells were co-immunoprecipitated with control IgG or anti-SAV1 antibody, followed by immunoblotting with an anti-EGFR antibody. n = 3 biological replicates. D : Representative SAV1 and EGFR double staining in the MIO-M1 Müller cells was examined by immunofluorescence (IF) staining. Scale bar = 20 µm. E : Western blot assay for EGFR, SAV1 and YAP expression in the MIO-M1 Müller cells through gain or loss of function of EGFR. n = 3 biological replicates. F : Expression of YAP in the nucleus of MIO-M1 Müller cells with gain or loss of function of EGFR was detected by Western blotting. n = 3 biological replicates. G : RT-PCR assay for mRNA levels of CTGF and CYR61 in MIO-M1 Müller cells through gain or loss of function of EGFR. n = 5 biological replicates. * p < 0.05; ** p < 0.01

    Article Snippet: Specific antibodies targeting EGFR, SAV1, YAP, Herc4, ɑ-SMA, CTGF, fibronectin, vimentin, E-cadherin, and collagen I were purchased from Santa Cruz Biotechnology (TX).

    Techniques: Activation Assay, Immunoprecipitation, Control, Western Blot, Transfection, Expressing, Plasmid Preparation, Co-Immunoprecipitation Assay, Double Staining, Immunofluorescence, Staining, Reverse Transcription Polymerase Chain Reaction

    EGFR mediates SAV1 proteasomal degradation. A : RT-PCR assay for mRNA level of SAV1 in MIO-M1 Müller cells through gain or loss of function of EGFR; n = 5 biological replicates. B : Western blot assay for endogenous protein level of SAV1 in MIO-M1 Müller cells transfected with increasing amount of EGFR expression plasmid. n = 3 biological replicates. C : Western blot assay for EGFR and SAV1 expression in the MIO-M1 Müller cells with transfection of flag-EGFR plasmid treated with or without a proteasome inhibitor MG132 (20 mM) for 6 h. n = 3 biological replicates. D : Western blot assay for the half-life of endogenous SAV1 protein in MIO-M1 Müller cells transfected with flag-EGFR and treated with cycloheximide(CHX) at 100 µg/ml for the different times. n = 3 biological replicates. E : Western blot assay for the half-life of endogenous SAV1 protein in MIO-M1 Müller cells transfected with EGFR-siRNA and treated with CHX at 100 µg/ml for the different times. n = 3 biological replicates. * p < 0.05; ** p < 0.01

    Journal: Journal of Translational Medicine

    Article Title: The epidermal growth factor receptor regulates YAP signalling and promotes diabetic retinal fibrosis by modulating the degradation of SAV1

    doi: 10.1186/s12967-025-07357-7

    Figure Lengend Snippet: EGFR mediates SAV1 proteasomal degradation. A : RT-PCR assay for mRNA level of SAV1 in MIO-M1 Müller cells through gain or loss of function of EGFR; n = 5 biological replicates. B : Western blot assay for endogenous protein level of SAV1 in MIO-M1 Müller cells transfected with increasing amount of EGFR expression plasmid. n = 3 biological replicates. C : Western blot assay for EGFR and SAV1 expression in the MIO-M1 Müller cells with transfection of flag-EGFR plasmid treated with or without a proteasome inhibitor MG132 (20 mM) for 6 h. n = 3 biological replicates. D : Western blot assay for the half-life of endogenous SAV1 protein in MIO-M1 Müller cells transfected with flag-EGFR and treated with cycloheximide(CHX) at 100 µg/ml for the different times. n = 3 biological replicates. E : Western blot assay for the half-life of endogenous SAV1 protein in MIO-M1 Müller cells transfected with EGFR-siRNA and treated with CHX at 100 µg/ml for the different times. n = 3 biological replicates. * p < 0.05; ** p < 0.01

    Article Snippet: Specific antibodies targeting EGFR, SAV1, YAP, Herc4, ɑ-SMA, CTGF, fibronectin, vimentin, E-cadherin, and collagen I were purchased from Santa Cruz Biotechnology (TX).

    Techniques: Reverse Transcription Polymerase Chain Reaction, Western Blot, Transfection, Expressing, Plasmid Preparation

    EGFR mediates SAV1 degradation through promoting its binding to Herc4. A : Lysates from MIO-M1 Müller cells were co-immunoprecipitated with control IgG or anti-EGFR antibody, followed by immunoblotting with an anti-Herc4 antibody. n = 3 biological replicates. B : MIO-M1 Müller cells were transfected with flag-EGFR expression plasmid. The co-immunoprecipitation assay was performed using lysates from MIO-M1 Müller cells by an anti-flag antibody, followed by immunoblotting with an anti-Herc4 antibody. n = 3 biological replicates. C : Representative Herc4 and EGFR double staining in the MIO-M1 Müller cells was examined by immunohistochemical measurement. Scale bar = 20 µm. D : Total lysate was extracted from MIO-M1 Müller cells for two-step coIP. The first ip was performed with IgG or anti-EGFR antibody. The eluate from the first ip was then used for the second ip with anti-Herc4 antibody or IgG. n = 3 biological replicates. E : MIO-M1 Müller cells were transfected with flag-EGFR or flag plasmid. The co-immunoprecipitation assay was performed using lysates from MIO-M1 Müller cells by an anti-Herc4 antibody, followed by immunoblotting to detect SAV1 and Herc4. n = 3 biological replicates. F : MIO-M1 Müller cells were transfected with EGFR-siRNA or control-siRNA. The co-immunoprecipitation assay was performed using lysates from MIO-M1 Müller cells by an anti-Herc4 antibody, followed by immunoblotting to detect SAV1 and Herc4. G : Western blot assay for Herc4, YAP and SAV1 expression in the MIO-M1 Müller cells with transfection of flag-EGFR plasmid and co-transected with or without Herc4-siRNA. n = 3 biological replicates. * p < 0.05; ** p < 0.01

    Journal: Journal of Translational Medicine

    Article Title: The epidermal growth factor receptor regulates YAP signalling and promotes diabetic retinal fibrosis by modulating the degradation of SAV1

    doi: 10.1186/s12967-025-07357-7

    Figure Lengend Snippet: EGFR mediates SAV1 degradation through promoting its binding to Herc4. A : Lysates from MIO-M1 Müller cells were co-immunoprecipitated with control IgG or anti-EGFR antibody, followed by immunoblotting with an anti-Herc4 antibody. n = 3 biological replicates. B : MIO-M1 Müller cells were transfected with flag-EGFR expression plasmid. The co-immunoprecipitation assay was performed using lysates from MIO-M1 Müller cells by an anti-flag antibody, followed by immunoblotting with an anti-Herc4 antibody. n = 3 biological replicates. C : Representative Herc4 and EGFR double staining in the MIO-M1 Müller cells was examined by immunohistochemical measurement. Scale bar = 20 µm. D : Total lysate was extracted from MIO-M1 Müller cells for two-step coIP. The first ip was performed with IgG or anti-EGFR antibody. The eluate from the first ip was then used for the second ip with anti-Herc4 antibody or IgG. n = 3 biological replicates. E : MIO-M1 Müller cells were transfected with flag-EGFR or flag plasmid. The co-immunoprecipitation assay was performed using lysates from MIO-M1 Müller cells by an anti-Herc4 antibody, followed by immunoblotting to detect SAV1 and Herc4. n = 3 biological replicates. F : MIO-M1 Müller cells were transfected with EGFR-siRNA or control-siRNA. The co-immunoprecipitation assay was performed using lysates from MIO-M1 Müller cells by an anti-Herc4 antibody, followed by immunoblotting to detect SAV1 and Herc4. G : Western blot assay for Herc4, YAP and SAV1 expression in the MIO-M1 Müller cells with transfection of flag-EGFR plasmid and co-transected with or without Herc4-siRNA. n = 3 biological replicates. * p < 0.05; ** p < 0.01

    Article Snippet: Specific antibodies targeting EGFR, SAV1, YAP, Herc4, ɑ-SMA, CTGF, fibronectin, vimentin, E-cadherin, and collagen I were purchased from Santa Cruz Biotechnology (TX).

    Techniques: Binding Assay, Immunoprecipitation, Control, Western Blot, Transfection, Expressing, Plasmid Preparation, Co-Immunoprecipitation Assay, Double Staining, Immunohistochemical staining

    Inhibition of EGFR suppresses YAP activation and alleviates diabetic retinal fibrosis. A : The diabetic mice models were randomized to treatment with erlotinib ( n = 10) or vehicle ( n = 10) beginning immediately after pvr induction. Control mice were also treatment with vehicle or Erlotinib( n = 10). B : Western blot assay for EGFR, SAV1, and YAP expression in the retinas of diabetic mice with or without erlotinib. n = 3 mice. C : Representative SAV1 and YAP staining in the retinas of diabetic mice with or without erlotinib was examined by immunohistochemical measurement. Scale bar = 50 µm. D : Western blot assay for ɑ-SMA, fibronectin, vimentin and E-cadherin expression in the retinas of diabetic mice with or without erlotinib. n = 3 mice. E : Representative images of Masson’s staining in the retinas of diabetic mice with or without erlotinib (black arrow indicates the presence of epiretinal fibrotic membrane). F : Western blot assay for E-cadherin, fibronectin, collagen I and ɑ-SMA expression in the MIO-M1 Müller cells through gain or loss of function of EGFR. n = 3 biological replicates. G : Western blot assay for YAP, EGFR, collagen I, and ɑ-SMA expression in the MIO-M1 Müller cells with transfection of flag-YAP plasmid and co-transected with or without EGFR-siRNA. n = 3 biological replicates. * p < 0.05; ** p < 0.01

    Journal: Journal of Translational Medicine

    Article Title: The epidermal growth factor receptor regulates YAP signalling and promotes diabetic retinal fibrosis by modulating the degradation of SAV1

    doi: 10.1186/s12967-025-07357-7

    Figure Lengend Snippet: Inhibition of EGFR suppresses YAP activation and alleviates diabetic retinal fibrosis. A : The diabetic mice models were randomized to treatment with erlotinib ( n = 10) or vehicle ( n = 10) beginning immediately after pvr induction. Control mice were also treatment with vehicle or Erlotinib( n = 10). B : Western blot assay for EGFR, SAV1, and YAP expression in the retinas of diabetic mice with or without erlotinib. n = 3 mice. C : Representative SAV1 and YAP staining in the retinas of diabetic mice with or without erlotinib was examined by immunohistochemical measurement. Scale bar = 50 µm. D : Western blot assay for ɑ-SMA, fibronectin, vimentin and E-cadherin expression in the retinas of diabetic mice with or without erlotinib. n = 3 mice. E : Representative images of Masson’s staining in the retinas of diabetic mice with or without erlotinib (black arrow indicates the presence of epiretinal fibrotic membrane). F : Western blot assay for E-cadherin, fibronectin, collagen I and ɑ-SMA expression in the MIO-M1 Müller cells through gain or loss of function of EGFR. n = 3 biological replicates. G : Western blot assay for YAP, EGFR, collagen I, and ɑ-SMA expression in the MIO-M1 Müller cells with transfection of flag-YAP plasmid and co-transected with or without EGFR-siRNA. n = 3 biological replicates. * p < 0.05; ** p < 0.01

    Article Snippet: Specific antibodies targeting EGFR, SAV1, YAP, Herc4, ɑ-SMA, CTGF, fibronectin, vimentin, E-cadherin, and collagen I were purchased from Santa Cruz Biotechnology (TX).

    Techniques: Inhibition, Activation Assay, Control, Western Blot, Expressing, Staining, Immunohistochemical staining, Membrane, Transfection, Plasmid Preparation